Question 1

What is the catalog number for UGT1A1 Peptide - middle region?

Accepted Answer

The catalog number for UGT1A1 Peptide - middle region is orb1997836.

Question 2

What sizes are available for UGT1A1 Peptide - middle region?

Accepted Answer

UGT1A1 Peptide - middle region is available in the following size(s): 100 µg.

Question 3

Is UGT1A1 Peptide - middle region in stock?

Accepted Answer

UGT1A1 Peptide - middle region is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What is UGT1A1 Peptide - middle region used for?

Accepted Answer

UGT1A1 Peptide - middle region

Question 5

Is this product animal-origin-free?

Accepted Answer

Animal-origin-free status, where applicable, is noted on the datasheet under formulation details.

Question 6

Does this product need any special customs documentation to be imported to my country?

Accepted Answer

If you’re outside the EU, UK, or USA, you’re responsible for customs clearance and any related taxes or fees. We provide the standard import documents, such as the Commercial Invoice, Packing List, and Airway Bill, in advance, so let us know early if your customs office needs anything additional for this specific product.

Question 7

What buffer is this product supplied in?

Accepted Answer

The formulation or storage buffer is listed on the product datasheet. If you require a carrier-free or custom formulation, contact us before ordering, as this may involve a made-to-order production timeline.

UGT1A1 Peptide - middle region

Product Specifications

Product Name Alternative

UniProt

Field of Research

Form

Storage Conditions

Notes

NCBI Accession Number

Preservative

AA Sequence

Frequently Asked Questions

Explore Other Products

trfp (MED20) (NM_004275) Human Over-expression Lysate

Annexin V-APC/Cyanine7 Reagent

Annexin V-APC/Cyanine7 Reagent

SOX10 (Melanoma Marker) (rSOX10/1074), CF405S conjugate, 0.1mg/mL

Prohibitin (Mitochondrial Marker) (PHB/3230), CF647 conjugate, 0.1mg/mL

Octylphosphonic Acid (NOPA)